Insitro focuses on drug discovery and development in the pharmaceutical research sector. The company utilizes machine learning and biological tools to create predictive models that help identify successful paths for developing new medicines. By doing so, Insitro aims to minimize the costly failures that often occur in pharmaceutical R&D. Their team, which includes scientists and engineers, collaborates to generate and analyze data to enhance the drug discovery process. Unlike traditional methods that rely heavily on intuition, Insitro's approach is data-driven and seeks to provide more accurate predictions. The company primarily serves pharmaceutical companies, healthcare providers, and research institutions looking for efficient drug development solutions. Insitro's goal is to improve the overall effectiveness and efficiency of the drug discovery process.